menu
    • menu

    Company profile for Resverlogix

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Resverlogix Corp. is a late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. We provide novel science, clinical and value-based health solutions to key stakeholders such as pharmaceutical, physician, and health payer groups. In 2005, Resverlogix commenced trading on the TSX under the symbol RVX. Resverlogix is a pioneer in the landscape of epigenetics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ResverlogixCanada Flag
    Country
    Country
    Canada
    Address
    Address
    300, 4820 Richard Road SW Calgary, AB, T3E 6L1
    Telephone
    Telephone
    403.254.9252
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    https://in.linkedin.com/company/resverlogix-corp-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/resverlogix_rvx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    InvestmentPitch Media Video Discusses Resverlogix & Focus Apabetalone’s Future
    InvestmentPitch Media Video Discusses Resverlogix & Focus Apabetalone’s Future

    30 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/30/2525815/0/en/InvestmentPitch-Media-Video-Discusses-Resverlogix-and-its-Focus-on-Apabetalone-s-Future-Development-for-the-Prevention-and-Treatment-of-Post-COVID-19-Conditions.html

    GLOBENEWSWIRE
    30 Sep 2022
    Share Share
    Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions
    Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

    28 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/28/2524164/0/en/Resverlogix-Confirms-Focus-on-Treatment-of-Post-COVID-19-Conditions.html

    GLOBENEWSWIRE
    28 Sep 2022
    Share Share
    Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit
    Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit

    22 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/22/2502072/0/en/Resverlogix-Publishes-New-Data-Highlighting-Apabetalone-s-Benefit-in-Non-alcoholic-Fatty-Liver-Disease.html

    GLOBENEWSWIRE
    22 Aug 2022
    Share Share
    Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders
    Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders

    21 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/22/2466722/0/en/Resverlogix-Announces-Voting-Results-from-the-2022-Meeting-of-Shareholders.html

    GLOBENEWSWIRE
    21 Jun 2022
    Share Share
    Resverlogix's Research Data Highlights Safety of BD2-selective BET Inhibitors
    Resverlogix's Research Data Highlights Safety of BD2-selective BET Inhibitors

    08 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/08/2458596/0/en/Resverlogix-Announces-New-Research-Findings-Highlighting-the-Safety-of-BD2-selective-BET-Inhibitors.html

    GLOBENEWSWIRE
    08 Jun 2022
    Share Share
    Resverlogix Announces Type C Meeting with FDA for CORAL, PIII Study
    Resverlogix Announces Type C Meeting with FDA for CORAL, PIII Study

    09 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/09/2438456/0/en/Resverlogix-Announces-Type-C-Meeting-with-FDA-for-CORAL-a-Phase-3-High-risk-COVID-19-Outpatient-Study.html

    GLOBENEWSWIRE
    09 May 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search